Technical Analysis for IVA - Inventiva S.A.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 3.08 | -2.53% | -0.08 |
IVA closed down 2.47 percent on Thursday, April 25, 2024, on 53 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | -2.53% | |
| Narrow Range Bar | Range Contraction | -2.53% | |
| Stochastic Reached Oversold | Weakness | -2.53% | |
| Inside Day | Range Contraction | -2.53% | |
| Down 3 Days in a Row | Weakness | -2.53% | |
| Down 4 Days in a Row | Weakness | -2.53% | |
| Down 5 Days in a Row | Weakness | -2.53% | |
| Gapped Down | Weakness | -2.53% | |
| Oversold Stochastic | Weakness | -2.53% | |
| Down 3 Days in a Row | Weakness | -4.94% |
| Alert | Time |
|---|---|
| Down 2 % | 6 minutes ago |
| Fell Below Previous Day's Low | 26 minutes ago |
| Down 1% | 26 minutes ago |
| 60 Minute Opening Range Breakdown | about 20 hours ago |
| Possible NR7 | about 20 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/29/2024
Inventiva SA engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centred on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Alcohol Genetics Gene Expression Hepatitis Steatohepatitis Non Alcoholic Fatty Liver Disease DNA Fibrosis Small Molecule Therapies Transcription Transcription Factors Epigenetics Transcription Factor Hepatitis A
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Alcohol Genetics Gene Expression Hepatitis Steatohepatitis Non Alcoholic Fatty Liver Disease DNA Fibrosis Small Molecule Therapies Transcription Transcription Factors Epigenetics Transcription Factor Hepatitis A
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5.04 |
| 52 Week Low | 2.439 |
| Average Volume | 46,370 |
| 200-Day Moving Average | 3.90 |
| 50-Day Moving Average | 3.65 |
| 20-Day Moving Average | 3.52 |
| 10-Day Moving Average | 3.31 |
| Average True Range | 0.22 |
| RSI (14) | 36.31 |
| ADX | 15.06 |
| +DI | 18.18 |
| -DI | 26.01 |
| Chandelier Exit (Long, 3 ATRs) | 3.31 |
| Chandelier Exit (Short, 3 ATRs) | 3.72 |
| Upper Bollinger Bands | 3.99 |
| Lower Bollinger Band | 3.06 |
| Percent B (%b) | 0.11 |
| BandWidth | 26.47 |
| MACD Line | -0.14 |
| MACD Signal Line | -0.11 |
| MACD Histogram | -0.0377 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.25 | ||||
| Resistance 3 (R3) | 3.24 | 3.20 | 3.23 | ||
| Resistance 2 (R2) | 3.20 | 3.18 | 3.20 | 3.23 | |
| Resistance 1 (R1) | 3.18 | 3.16 | 3.19 | 3.19 | 3.22 |
| Pivot Point | 3.14 | 3.14 | 3.15 | 3.15 | 3.14 |
| Support 1 (S1) | 3.12 | 3.12 | 3.13 | 3.13 | 3.10 |
| Support 2 (S2) | 3.08 | 3.10 | 3.09 | 3.09 | |
| Support 3 (S3) | 3.06 | 3.08 | 3.09 | ||
| Support 4 (S4) | 3.07 |
